chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: m their arm was itchy, swelling a little, red and feverish at the injection site; their arm was itchy, swelling a little, red and feverish at the injection site; their arm was itchy, swelling a little, red and feverish at the injection site; their arm was itchy, swelling a little, red and feverish at the injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (m their arm was itchy, swelling a little, red and feverish at the injection site), VACCINATION SITE PRURITUS (their arm was itchy, swelling a little, red and feverish at the injection site), VACCINATION SITE SWELLING (their arm was itchy, swelling a little, red and feverish at the injection site) and VACCINATION SITE ERYTHEMA (their arm was itchy, swelling a little, red and feverish at the injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included ZINC, VITAMIN C [ASCORBIC ACID] and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced VACCINATION SITE WARMTH (m their arm was itchy, swelling a little, red and feverish at the injection site), VACCINATION SITE PRURITUS (their arm was itchy, swelling a little, red and feverish at the injection site), VACCINATION SITE SWELLING (their arm was itchy, swelling a little, red and feverish at the injection site) and VACCINATION SITE ERYTHEMA (their arm was itchy, swelling a little, red and feverish at the injection site). At the time of the report, VACCINATION SITE WARMTH (m their arm was itchy, swelling a little, red and feverish at the injection site), VACCINATION SITE PRURITUS (their arm was itchy, swelling a little, red and feverish at the injection site), VACCINATION SITE SWELLING (their arm was itchy, swelling a little, red and feverish at the injection site) and VACCINATION SITE ERYTHEMA (their arm was itchy, swelling a little, red and feverish at the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       anti-itch cream used as a treatment medication.
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper
Clinical narrative: stomach ache after receiving the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach ache after receiving the vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (stomach ache after receiving the vaccine). At the time of the report, ABDOMINAL PAIN UPPER (stomach ache after receiving the vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.   Reporter did not allow further contact
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Paraesthesia, Pruritus
Clinical narrative: my left arm started to feel tingly, itchy, hot; my left arm started to feel tingly, itchy, hot; my left arm started to feel tingly, itchy, hot; Red; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (my left arm started to feel tingly, itchy, hot), PRURITUS (my left arm started to feel tingly, itchy, hot), FEELING HOT (my left arm started to feel tingly, itchy, hot) and ERYTHEMA (Red) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced PARAESTHESIA (my left arm started to feel tingly, itchy, hot), PRURITUS (my left arm started to feel tingly, itchy, hot), FEELING HOT (my left arm started to feel tingly, itchy, hot) and ERYTHEMA (Red). On 01-Feb-2021, PARAESTHESIA (my left arm started to feel tingly, itchy, hot), PRURITUS (my left arm started to feel tingly, itchy, hot) and FEELING HOT (my left arm started to feel tingly, itchy, hot) had resolved. At the time of the report, ERYTHEMA (Red) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and NAUSEA (nausea) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE and PARACETAMOL (TYLENOL) for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced HEADACHE (headache) and NAUSEA (nausea). At the time of the report, HEADACHE (headache) and NAUSEA (nausea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Tylenol used as a Treatment Medication.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Rash pruritic, Urticaria
Clinical narrative: Welt on arm for first few days. It seemed to go away and came back itchy and red after a week.  It seems to have gotten slightly bigger the last day or two.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching all over the body) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No medical history was provided by the reporter. .  Concomitant products included ATORVASTATIN, VALSARTAN, FAMOTIDINE, CETIRIZINE, FINASTERIDE, ATENOLOL, HYDROCHLOROTHIAZIDE, CALCITRIOL, APIXABAN and GABAPENTIN for an unknown indication.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PRURITUS (Itching all over the body). At the time of the report, PRURITUS (Itching all over the body) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The treatment information was None + concomitant.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Delayed adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Delayed adverse reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Delayed adverse reaction). At the time of the report, VACCINATION COMPLICATION (Delayed adverse reaction) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site swelling
Clinical narrative: site of the injection was swollen and itching; site of the injection was swollen and itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (site of the injection was swollen and itching) and VACCINATION SITE SWELLING (site of the injection was swollen and itching) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes mellitus, Blood pressure, Hyperlipidemia and Allergy. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for Allergy.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (site of the injection was swollen and itching) and VACCINATION SITE SWELLING (site of the injection was swollen and itching). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (site of the injection was swollen and itching) and VACCINATION SITE SWELLING (site of the injection was swollen and itching) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Pain in extremity
Clinical narrative: SORE ARM; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (SORE ARM) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (SORE ARM). On 29-Jan-2021, PAIN IN EXTREMITY (SORE ARM) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Jan-2021, Heart rate: (High) HR is higher than normal (from 60 to 80).     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Oropharyngeal pain, Pain
Clinical narrative: positive for COVID-19; fever; worse cough; body aches; chills; sore throat; minor cough; This spontaneous case was reported by a physician and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), COUGH (minor cough), COUGH (worse cough), COVID-19 (positive for COVID-19) and PAIN (body aches) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat) and COUGH (minor cough). On 11-Jan-2021, the patient experienced COUGH (worse cough), PAIN (body aches) and CHILLS (chills). On 13-Jan-2021, the patient experienced COVID-19 (positive for COVID-19) and PYREXIA (fever). The patient was treated with VITAMINS NOS at a dose of 1 dosage form; GUAIFENESIN (MUCINEX) at a dose of 1 dosage form; DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) at a dose of 1 dosage form; DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) at a dose of 1 dosage form; DEXAMETHASONE at a dose of 1 dosage form and AZITHROMYCIN at a dose of 1 dosage form. At the time of the report, OROPHARYNGEAL PAIN (sore throat), COUGH (minor cough), COUGH (worse cough), COVID-19 (positive for COVID-19), PAIN (body aches), CHILLS (chills) and PYREXIA (fever) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Jan-2021, SARS-CoV-2 test: (Inconclusive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator No treatment medications provided by the reporter.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: positive for COVID-19; fever; worse cough; body aches; chills; sore throat; minor cough; This spontaneous case was reported by a physician and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), COUGH (minor cough), COUGH (worse cough), COVID-19 (positive for COVID-19) and PAIN (body aches) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat) and COUGH (minor cough). On 11-Jan-2021, the patient experienced COUGH (worse cough), PAIN (body aches) and CHILLS (chills). On 13-Jan-2021, the patient experienced COVID-19 (positive for COVID-19) and PYREXIA (fever). The patient was treated with VITAMINS NOS at a dose of 1 dosage form; GUAIFENESIN (MUCINEX) at a dose of 1 dosage form; DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) at a dose of 1 dosage form; DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) at a dose of 1 dosage form; DEXAMETHASONE at a dose of 1 dosage form and AZITHROMYCIN at a dose of 1 dosage form. At the time of the report, OROPHARYNGEAL PAIN (sore throat), COUGH (minor cough), COUGH (worse cough), COVID-19 (positive for COVID-19), PAIN (body aches), CHILLS (chills) and PYREXIA (fever) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Jan-2021, SARS-CoV-2 test: (Inconclusive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator No treatment medications provided by the reporter.
Age: 80.0
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash, Vaccination site warmth
Clinical narrative: red rash at the injection site; itchy at the injection site; warm to the touch at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (red rash at the injection site), VACCINATION SITE PRURITUS (itchy at the injection site) and VACCINATION SITE WARMTH (warm to the touch at injection site) in an 80-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE RASH (red rash at the injection site), VACCINATION SITE PRURITUS (itchy at the injection site) and VACCINATION SITE WARMTH (warm to the touch at injection site). At the time of the report, VACCINATION SITE RASH (red rash at the injection site) and VACCINATION SITE WARMTH (warm to the touch at injection site) had not resolved and VACCINATION SITE PRURITUS (itchy at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Flushing, Heart rate, Swollen tongue
Clinical narrative: Flushing; Dizzy; Tongue was swollen; Chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FLUSHING (Flushing), DIZZINESS (Dizzy), SWOLLEN TONGUE (Tongue was swollen) and CHILLS (Chills) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for an unknown indication.     No Medical History information was reported.    On 09-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced FLUSHING (Flushing), DIZZINESS (Dizzy), SWOLLEN TONGUE (Tongue was swollen) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form; CETIRIZINE HYDROCHLORIDE (BENADRYL ALLERGY [CETIRIZINE HYDROCHLORIDE]) at a dose of 1 dosage form and NAPROXEN at a dose of 500 milligram twice a day. At the time of the report, FLUSHING (Flushing), DIZZINESS (Dizzy), SWOLLEN TONGUE (Tongue was swollen) and CHILLS (Chills) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Jan-2021, Heart rate: (High) went to the ER for her heart rate since it was elevated in 130-140s.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: get a headache from neck surgery once in a while; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (get a headache from neck surgery once in a while) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Neck surgery.    On 26-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (get a headache from neck surgery once in a while). At the time of the report, HEADACHE (get a headache from neck surgery once in a while) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site warmth
Clinical narrative: Arm is hard, red and hot at the injection site, about the size of a softball; Arm is hardt at the injection site, about the size of a softball; Arm is hard, red and hot at the injection site, about the size of a softball; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Arm is hard, red and hot at the injection site, about the size of a softball), VACCINATION SITE INDURATION (Arm is hardt at the injection site, about the size of a softball) and VACCINATION SITE ERYTHEMA (Arm is hard, red and hot at the injection site, about the size of a softball) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Arm is hard, red and hot at the injection site, about the size of a softball), VACCINATION SITE INDURATION (Arm is hardt at the injection site, about the size of a softball) and VACCINATION SITE ERYTHEMA (Arm is hard, red and hot at the injection site, about the size of a softball). At the time of the report, VACCINATION SITE WARMTH (Arm is hard, red and hot at the injection site, about the size of a softball), VACCINATION SITE INDURATION (Arm is hardt at the injection site, about the size of a softball) and VACCINATION SITE ERYTHEMA (Arm is hard, red and hot at the injection site, about the size of a softball) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site urticaria
Clinical narrative: The rash continues; Injection site itching; injection site is still red; Hives from injection site down to the elbow; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of RASH (The rash continues), VACCINATION SITE URTICARIA (Hives from injection site down to the elbow), VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE PAIN (Soreness) and VACCINATION SITE ERYTHEMA (injection site is still red) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included Hives (Patient  had hives 3 times and after her child was born 2 other times.). Family history included Autoimmune disorder (history of autoimmunity in her family.) since an unknown date. Concurrent medical conditions included Seasonal allergy.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness). On 23-Jan-2021, the patient experienced VACCINATION SITE URTICARIA (Hives from injection site down to the elbow). On 24-Jan-2021, the patient experienced RASH (The rash continues), VACCINATION SITE PRURITUS (Injection site itching) and VACCINATION SITE ERYTHEMA (injection site is still red). On 24-Jan-2021, VACCINATION SITE URTICARIA (Hives from injection site down to the elbow) had resolved. At the time of the report, RASH (The rash continues), VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE PAIN (Soreness) and VACCINATION SITE ERYTHEMA (injection site is still red) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include something for the thyroid.  No treatment information was reported.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Diagnosed positive of COVID-19 after receiving the first dose of the Moderna COVID-19 Vaccine) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included COVID-19 (diagnosed after receiving first dose of vaccine) since 22-Jan-2021.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (Diagnosed positive of COVID-19 after receiving the first dose of the Moderna COVID-19 Vaccine). At the time of the report, SARS-COV-2 TEST POSITIVE (Diagnosed positive of COVID-19 after receiving the first dose of the Moderna COVID-19 Vaccine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, SARS-CoV-2 test positive: positive.         No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Positive Covid Test; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (Positive Covid Test) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included RAMIPRIL (ALTACE), ACETYLSALICYLIC ACID (BABY ASPIRIN), HYDROCHLOROTHIAZIDE, ROSUVASTATIN CALCIUM (CRESTOR), ZOLPIDEM TARTRATE (AMBIEN CR), PARACETAMOL (TYLENOL 8 HOUR), IBUPROFEN, ASCORBIC ACID (VITAMIN C ACID), BIOTIN and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Positive Covid Test). At the time of the report, SARS-COV-2 TEST POSITIVE (Positive Covid Test) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Jan-2021, SARS-CoV-2 test: (Positive) Positive Covid Test.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea, SARS-CoV-2 test, Vaccination complication, Vomiting
Clinical narrative: Adverse reaction/Many Symptoms; Diarrhea; Nausea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Adverse reaction/Many Symptoms), DIARRHOEA (Diarrhea), NAUSEA (Nausea) and VOMITING (Vomiting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced DIARRHOEA (Diarrhea), NAUSEA (Nausea) and VOMITING (Vomiting). On an unknown date, the patient experienced VACCINATION COMPLICATION (Adverse reaction/Many Symptoms). At the time of the report, VACCINATION COMPLICATION (Adverse reaction/Many Symptoms), DIARRHOEA (Diarrhea), NAUSEA (Nausea) and VOMITING (Vomiting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.   Reporter did not allow further contact
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Swelling, Vaccination site erythema, Vaccination site pain
Clinical narrative: swelling; rash at 3 inch of diameter; red at site of injection; her ram was sore; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling), RASH (rash at 3 inch of diameter), VACCINATION SITE ERYTHEMA (red at site of injection) and VACCINATION SITE PAIN (her ram was sore) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in September 2020.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced SWELLING (swelling), RASH (rash at 3 inch of diameter), VACCINATION SITE ERYTHEMA (red at site of injection) and VACCINATION SITE PAIN (her ram was sore). At the time of the report, SWELLING (swelling), RASH (rash at 3 inch of diameter), VACCINATION SITE ERYTHEMA (red at site of injection) and VACCINATION SITE PAIN (her ram was sore) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: Delayed flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Delayed flu like symptoms) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INFLUENZA LIKE ILLNESS (Delayed flu like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (Delayed flu like symptoms) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Dry mouth, Pain in extremity, Pleurisy
Clinical narrative: mouth so dry; pain on his lungs; sore arm; loss of sense of taste; loss of sense of smell; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (sore arm), AGEUSIA (loss of sense of taste), ANOSMIA (loss of sense of smell), DRY MOUTH (mouth so dry) and PLEURISY (pain on his lungs) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for an unknown indication.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm), AGEUSIA (loss of sense of taste) and ANOSMIA (loss of sense of smell). On 30-Jan-2021, the patient experienced DRY MOUTH (mouth so dry) and PLEURISY (pain on his lungs). At the time of the report, PAIN IN EXTREMITY (sore arm), AGEUSIA (loss of sense of taste), ANOSMIA (loss of sense of smell) and DRY MOUTH (mouth so dry) outcome was unknown and PLEURISY (pain on his lungs) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   concomitant medication was not  provided by reporter. treatment information was not provided.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral nerve decompression, Pruritus, Swelling
Clinical narrative: Arm was itchy; Arm was swollen; hit ulnar nerve; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Arm was itchy), SWELLING (Arm was swollen) and PERIPHERAL NERVE DECOMPRESSION (hit ulnar nerve) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included Graves' disease, Hypoglycaemia and Malabsorption. Concurrent medical conditions included Penicillin allergy, Drug allergy (patient is allergic to Imitrex,sulfa drug, codeine, digitalis, vitamin c tablet.), Food allergy (Patient is allergic to shell fish, honey.), Fruit allergy (everything with same Amino Acid as pineapple, tomato, orange, kiwi, avocado.), Allergy to chemicals and Allergy to insect sting (patient is allergic to bees, wasp.).    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced PRURITUS (Arm was itchy), SWELLING (Arm was swollen) and PERIPHERAL NERVE DECOMPRESSION (hit ulnar nerve). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and CORTISONE at an unspecified dose and frequency. At the time of the report, PRURITUS (Arm was itchy), SWELLING (Arm was swollen) and PERIPHERAL NERVE DECOMPRESSION (hit ulnar nerve) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment included Bendryl and cortisone ointment.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Warm; Swollen arm; rash on her arm/the size of the rash was about the size of a tennis ball; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm), VACCINATION SITE SWELLING (Swollen arm) and VACCINATION SITE RASH (rash on her arm/the size of the rash was about the size of a tennis ball) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Warm), VACCINATION SITE SWELLING (Swollen arm) and VACCINATION SITE RASH (rash on her arm/the size of the rash was about the size of a tennis ball). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] (oral) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Warm), VACCINATION SITE SWELLING (Swollen arm) and VACCINATION SITE RASH (rash on her arm/the size of the rash was about the size of a tennis ball) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided.  Treatment includes ice on and off.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: follow up received from 11-JUN-2021 :Patient said she is doing fine and declined for further follow-up
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Fatigue, Hypoaesthesia, Limb discomfort, Musculoskeletal discomfort
Clinical narrative: Felt all shaky; Discomfort in my armpit; Discomfort in my chest; Discomfort in my back; Nervous; Discomfort in my shoulder blade; Yawning more than usual; Tired; Little nauseous; little discomfort on her shoulder blade; Tingling in my left arm; Numbness in my left arm; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling in my left arm), HYPOAESTHESIA (Numbness in my left arm), TREMOR (Felt all shaky), LIMB DISCOMFORT (Discomfort in my armpit) and CHEST DISCOMFORT (Discomfort in my chest) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jan-2021 at 12:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced TREMOR (Felt all shaky), LIMB DISCOMFORT (Discomfort in my armpit), CHEST DISCOMFORT (Discomfort in my chest), MUSCULOSKELETAL DISCOMFORT (Discomfort in my back ), NERVOUSNESS (Nervous) and NAUSEA (Little nauseous). On 28-Jan-2021, the patient experienced PARAESTHESIA (Tingling in my left arm) and HYPOAESTHESIA (Numbness in my left arm). On an unknown date, the patient experienced MUSCULOSKELETAL DISCOMFORT (Discomfort in my shoulder blade), YAWNING (Yawning more than usual), FATIGUE (Tired) and MUSCULOSKELETAL DISCOMFORT (little discomfort on her shoulder blade). At the time of the report, PARAESTHESIA (Tingling in my left arm) and HYPOAESTHESIA (Numbness in my left arm) was resolving, TREMOR (Felt all shaky), LIMB DISCOMFORT (Discomfort in my armpit), NERVOUSNESS (Nervous), MUSCULOSKELETAL DISCOMFORT (Discomfort in my shoulder blade), YAWNING (Yawning more than usual), FATIGUE (Tired), NAUSEA (Little nauseous) and MUSCULOSKELETAL DISCOMFORT (little discomfort on her shoulder blade) outcome was unknown, CHEST DISCOMFORT (Discomfort in my chest) had not resolved and MUSCULOSKELETAL DISCOMFORT (Discomfort in my back ) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The pharmacist told her to take a Tylenol. No concomitant medication reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jan-2021: No specific follow-up information recorded.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Nervousness, Paraesthesia, Tremor, Yawning
Clinical narrative: Felt all shaky; Discomfort in my armpit; Discomfort in my chest; Discomfort in my back; Nervous; Discomfort in my shoulder blade; Yawning more than usual; Tired; Little nauseous; little discomfort on her shoulder blade; Tingling in my left arm; Numbness in my left arm; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling in my left arm), HYPOAESTHESIA (Numbness in my left arm), TREMOR (Felt all shaky), LIMB DISCOMFORT (Discomfort in my armpit) and CHEST DISCOMFORT (Discomfort in my chest) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jan-2021 at 12:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced TREMOR (Felt all shaky), LIMB DISCOMFORT (Discomfort in my armpit), CHEST DISCOMFORT (Discomfort in my chest), MUSCULOSKELETAL DISCOMFORT (Discomfort in my back ), NERVOUSNESS (Nervous) and NAUSEA (Little nauseous). On 28-Jan-2021, the patient experienced PARAESTHESIA (Tingling in my left arm) and HYPOAESTHESIA (Numbness in my left arm). On an unknown date, the patient experienced MUSCULOSKELETAL DISCOMFORT (Discomfort in my shoulder blade), YAWNING (Yawning more than usual), FATIGUE (Tired) and MUSCULOSKELETAL DISCOMFORT (little discomfort on her shoulder blade). At the time of the report, PARAESTHESIA (Tingling in my left arm) and HYPOAESTHESIA (Numbness in my left arm) was resolving, TREMOR (Felt all shaky), LIMB DISCOMFORT (Discomfort in my armpit), NERVOUSNESS (Nervous), MUSCULOSKELETAL DISCOMFORT (Discomfort in my shoulder blade), YAWNING (Yawning more than usual), FATIGUE (Tired), NAUSEA (Little nauseous) and MUSCULOSKELETAL DISCOMFORT (little discomfort on her shoulder blade) outcome was unknown, CHEST DISCOMFORT (Discomfort in my chest) had not resolved and MUSCULOSKELETAL DISCOMFORT (Discomfort in my back ) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The pharmacist told her to take a Tylenol. No concomitant medication reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jan-2021: No specific follow-up information recorded.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: rash at the site of injection; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE RASH (rash at the site of injection) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032H20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced VACCINATION SITE RASH (rash at the site of injection). At the time of the report, VACCINATION SITE RASH (rash at the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported. Treatment medication was not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041LZ019) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced CHILLS (chills). At the time of the report, CHILLS (chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. No relevant concomitant medications were reported.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Got tested positive for COVID and was asymptomatic; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Got tested positive for COVID and was asymptomatic) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Got tested positive for COVID and was asymptomatic). At the time of the report, COVID-19 (Got tested positive for COVID and was asymptomatic) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive POSITIVE.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were given No treatment information was provided
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Flushing, Tachycardia
Clinical narrative: Felt funny; fast heartbeat; flushing; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of   in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal and Blood cholesterol abnormal.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Ear pain, Headache, Oropharyngeal pain
Clinical narrative: Body aches; dizziness; ear ache; sore throat; experiencing fever; chills; headache; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN (Body aches), DIZZINESS (dizziness), EAR PAIN (ear ache), OROPHARYNGEAL PAIN (sore throat) and PYREXIA (experiencing fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 09L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN (Body aches), DIZZINESS (dizziness), EAR PAIN (ear ache), OROPHARYNGEAL PAIN (sore throat), PYREXIA (experiencing fever), CHILLS (chills) and HEADACHE (headache). At the time of the report, PAIN (Body aches), DIZZINESS (dizziness), EAR PAIN (ear ache), OROPHARYNGEAL PAIN (sore throat), PYREXIA (experiencing fever), CHILLS (chills) and HEADACHE (headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-022474, US-MODERNATX, INC.-MOD-2021-047944 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-047944:Crosslinked (MOD21-018034) US-MODERNATX, INC.-MOD-2021-022474:Crosslinked (MOD21-018034)
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Body aches; dizziness; ear ache; sore throat; experiencing fever; chills; headache; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN (Body aches), DIZZINESS (dizziness), EAR PAIN (ear ache), OROPHARYNGEAL PAIN (sore throat) and PYREXIA (experiencing fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 09L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN (Body aches), DIZZINESS (dizziness), EAR PAIN (ear ache), OROPHARYNGEAL PAIN (sore throat), PYREXIA (experiencing fever), CHILLS (chills) and HEADACHE (headache). At the time of the report, PAIN (Body aches), DIZZINESS (dizziness), EAR PAIN (ear ache), OROPHARYNGEAL PAIN (sore throat), PYREXIA (experiencing fever), CHILLS (chills) and HEADACHE (headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-022474, US-MODERNATX, INC.-MOD-2021-047944 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-047944:Crosslinked (MOD21-018034) US-MODERNATX, INC.-MOD-2021-022474:Crosslinked (MOD21-018034)